Baseline affective symptomatology moderates acute subjective effects of high potency THC and CBD cannabis concentrates.
Experimental and Clinical Psychopharmacology · 2023
DOI: 10.1037/pha0000667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Psychopharmacology, 2023. Verfasst von Renée Martin-Willett und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology and Neuroscience, University of Colorado Boulder. Hauptthemen laut MEDLINE: Cannabidiol, Cannabis, Hallucinogens. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, Sponsor name not included.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychology and Neuroscience, University of Colorado Boulder.
- Department of Psychology, Colorado State University.
ORCID-Profile: Renée Martin-Willett, Joshua S Elmore
Förderung
- NIAAA NIH HHS
- Sponsor name not included
Zitieren
APA
Martin-Willett, R., Skrzynski, C. J., Karoly, H. C., Elmore, J. S., & Bidwell, L. C. (2023). Baseline affective symptomatology moderates acute subjective effects of high potency THC and CBD cannabis concentrates. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000667
Vancouver
Martin-Willett R, Skrzynski CJ, Karoly HC, Elmore JS, Bidwell LC. Baseline affective symptomatology moderates acute subjective effects of high potency THC and CBD cannabis concentrates. Experimental and Clinical Psychopharmacology. 2023. doi:10.1037/pha0000667
BibTeX
@article{MartinWillett2023,
author = {Martin-Willett, Renée and Skrzynski, Carillon J and Karoly, Hollis C and Elmore, Joshua S and Bidwell, L Cinnamon},
title = {Baseline affective symptomatology moderates acute subjective effects of high potency THC and CBD cannabis concentrates},
journal = {Experimental and Clinical Psychopharmacology},
year = {2023},
doi = {10.1037/pha0000667}
}
EUVIMED